logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-105. All clients entering inpatient treatment by primary drug and age, 2011 or most recent year available

Part (vi) All volatile inhalant inpatient clients by country and age

Country<1515-1920-2425-2930-3435-3940-4445+Age knownAge not knownTotal
Belgium01000000101
Bulgaria00010100202
Czech Republic1205020010010
Denmark00000000000
Germany00012021606
Estonia:::::::::::
Ireland101000000101
Greece00000000000
Spain:::::::::::
France00000000000
Italy:::::::::::
Cyprus00000000000
Latvia:::::::::::
Lithuania:::::::::::
Luxembourg:::::::::::
Hungary14010000606
Malta:::::::::::
Netherlands00120000303
Austria00000000000
Poland2:::211:::::
Portugal:::::::::::
Romania16100001909
Slovenia:::::::::::
Slovakia4101015641050050
Finland00110000202
Sweden100100011303
United Kingdom300010010202
Croatia000230005::
Turkey4752421156111470147
Norway00000100101
Total119938522715642480243
 

Notes:

: Indicates no data are available.

(1) Data are from 2010.

(2) Data are from 2010. Data presented in the table come from TDI pilot project. Caution should be made when interpreting the data. Heroin includes both heroin and so called 'kompot' (heroin gained from the poppy straws).

(3) Data are from 1st of April 2010 to 31st March 2011.

See also Table TDI-10 part(vii), part(viii)

‘General notes for interpreting data'’ on the Explanatory notes and help page.

Source:

Reitox national reports 2012- Table TDI Inpatient Treatment Centres

Page last updated: Friday, 26 April 2013